Simon Goldman and David Grimm, who are responsible for managing investments for the UCL Technology Fund, the fund co-managed by UCLB and Albion Capital, have to [...]
UCLTF investment manager David Grimm recently spoke to Global University Venturing editor Thierry Heles to explain more about how the Fund is investing in UCL t [...]
UCLB spinout company, Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene [...]
UCLB spinout company, Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene [...]
UCL spin-out Matrix Mill Ltd, a company specialising in applying artificial intelligence and machine vision research to solve industry problems, has been acquir [...]
Matr, the online teaching platform, has announced it has closed a £4.75 million Series A investment round led by the UCL Technology Fund and Downing Ventures, w [...]
London, 19 June 2018 – Freeline Therapeutics Ltd (“Freeline”), a clinical stage company focused on treatment of chronic systemic diseases with liver targeted ad [...]
UCL Spinout MeiraGTx Holdings plc a vertically integrated, clinical stage gene therapy company, announced the closing of its initial public offering of 5,000,00 [...]
On Thursday 3rd May, the UCL Technology Fund hosted a showcase event, in celebration of the first two years of the £50 million fund. Co-managed by UCLB a [...]
Global University venturing has awarded the 2018 Deal of the Year Award to UCLB spinout, Orchard Therapeutics; a biotechnology company dedicated to transforming [...]
